OR WAIT null SECS
January 17, 2019
The companies will offer an IT platform that enhances the visibility and performance of the overall personalized medicine treatment process.
December 18, 2018
Agilent and other partners are funding development of Tapestri, a single-cell sequencing platform designed to help predict cancer relapse in individual patients and show the efficacy of gene-editing experiments.
December 17, 2018
December 13, 2018
A new facility in California will expand Orchard Therapeutic’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells.
November 30, 2018
Contract development and manufacturing organization (CDMO), Yposkesi, has entered into an agreement in principle with Axovant Sciences.
November 16, 2018
Moving forward with gene therapy development requires a “quantum leap” in manufacturing capabilities.
November 14, 2018
Improving the manufacturing of gene therapy vectors will be crucial to making advanced treatments accessible to more patients who need them, agreed panelists at the 2018 Galien Forum.
October 15, 2018
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
August 17, 2018
The acquisition will strengthen Astellas Pharma’s position in ophthalmology.
May 25, 2018
The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.